Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells

Lenvatinib is a tyrosine kinase receptor inhibitor used to treat unresectable hepatocellular carcinoma (HCC). In this study, we investigated the antitumor effects of Lenvatinib treatment on HCC cell lines. Proliferation was examined in four HCC cell lines (HuH-7, Hep3B, Li-7, and PLC/PRF/5) using Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakahara, Mai, Fujihara, Shintaro, Iwama, Hisakazu, Takuma, Kei, Oura, Kyoko, Tadokoro, Tomoko, Fujita, Koji, Tani, Joji, Morishita, Asahiro, Kobara, Hideki, Himoto, Takashi, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468852/
https://www.ncbi.nlm.nih.gov/pubmed/36158319
http://dx.doi.org/10.3892/br.2022.1561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468852/
https://www.ncbi.nlm.nih.gov/pubmed/36158319
http://dx.doi.org/10.3892/br.2022.1561

Ejemplares similares